APA

Eberhardt W. E. E., Gauler T. C., Lepechoux C., Stamatis G., Bildat S., Krbek T., Welter S., Grunenwald D., Fischer B., Rodrigo H. d. L. R., Theegarten D., Le Chevalier T., Seeber S., Stuschke M. & Poettgen C. (20140417). 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL). : Lung cancer (Amsterdam, Netherlands).

Chicago

Eberhardt Wilfried Ernst Erich, Gauler Thomas Christoph, Lepechoux Cecile, Stamatis Georgios, Bildat Stephan, Krbek Thomas, Welter Stefan, Grunenwald Dominique, Fischer Berthold, Rodrigo Hepp de Los Rios, Theegarten Dirk, Le Chevalier Thierry, Seeber Siegfried, Stuschke Martin and Poettgen Christoph. 20140417. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL). : Lung cancer (Amsterdam, Netherlands).

Harvard

Eberhardt W. E. E., Gauler T. C., Lepechoux C., Stamatis G., Bildat S., Krbek T., Welter S., Grunenwald D., Fischer B., Rodrigo H. d. L. R., Theegarten D., Le Chevalier T., Seeber S., Stuschke M. and Poettgen C. (20140417). 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL). : Lung cancer (Amsterdam, Netherlands).

MLA

Eberhardt Wilfried Ernst Erich, Gauler Thomas Christoph, Lepechoux Cecile, Stamatis Georgios, Bildat Stephan, Krbek Thomas, Welter Stefan, Grunenwald Dominique, Fischer Berthold, Rodrigo Hepp de Los Rios, Theegarten Dirk, Le Chevalier Thierry, Seeber Siegfried, Stuschke Martin and Poettgen Christoph. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL). : Lung cancer (Amsterdam, Netherlands). 20140417.